Anthony Maraveyas

14PUBLICATIONS
90CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Tissue engineeringHaematological tumoursCancer diagnosisPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Aug 25, 2025
Shared decision-making and deprescribing to support anti-thrombotic therapy (dis)continuance for persons living with cancer in their last phase of life: A realist synthesis.

Justin Jagosh, Mark Pearson, Sarah Greenley

|Feb 26, 2025
Identification of the Interacting Domains Between Tissue Factor and β1-Integrin and the Signalling Properties of the Two Fibronectin-like Domains of Tissue Factor.

Sophie J Featherby, Eamon C Faulkner, Anthony Maraveyas

|Sep 09, 2024
Temporary treatment cessation compared with continuation of tyrosine kinase inhibitors for adults with renal cancer: the STAR non-inferiority RCT.

Fiona Collinson, Kara-Louise Royle, Jayne Swain

|Apr 26, 2024
Cancer-associated venous thrombosis in adults (second edition): A British Society for Haematology Guideline.

Raza Alikhan, Keith Gomez, Anthony Maraveyas

|Nov 06, 2023
Standard Versus Modified Ipilimumab, in Combination With Nivolumab, in Advanced Renal Cell Carcinoma: A Randomized Phase II Trial (PRISM).

Naveen S Vasudev, Gemma Ainsworth, Sarah Brown

|Oct 25, 2022
Cancer patients' experiences of the diagnosis and treatment of incidental pulmonary embolism (a qualitative study).

Naima E Benelhaj, Ann Hutchinson, Anthony Maraveyas

Pageof 3

Frequent Collaborators

3 joint publications

Jeffrey I Zwicker

2 joint publications

Paul Nathan

2 joint publications

Annie Young

2 joint publications

Marcello Di Nisio